Drugs · acquisition-cost intelligence
Clobetasol Propionate
clobetasol propionate· ingredient clobetasolCorticosteroids, plain· CLOBETASOL PROPIONATE .5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.12147
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other clobetasol products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| clobetasol propionate | $0.11487 | −$0.00660 |
| Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05% | $0.15938 | +$0.03790 |
| clobetasol propionate | $0.17794 | +$0.05650 |
| Clobex | $0.24543 | +$0.12400 |
| clobetasol propionate | $0.32513 | +$0.20370 |
| CLOBEX | $0.33318 | +$0.21170 |
| Clobex | $0.34854 | +$0.22710 |
| Clobetasol Propionate (emollient) | $0.58990 | +$0.46840 |
Medicare Part D coverage · CY2026
On 306 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 67% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.